Cryoablation+Ipilimumab+Nivolumab in Melanoma

Summary

The aim of this study is to find out whether the combination of two approved drugs, ipilimumab and nivolumab, in combination with cryoablation are safe and effective for participants who have an unresectable melanoma that is resistant, or is growing, after receiving immunotherapy with a PD-1 inhibitor. The names of the study interventions involved in this study are: * Cryoablation (an interventional radiology procedure that freezes part of a tumor) * Ipilimumab (an immunotherapy) * Nivolumab (an immunotherapy)

Timeline

Start

2023-09-23

Primary completion

2028-01-01

Completion

2028-01-01

Drugs

Indications